| 1 |
Ozdemir AO, Tamayo A, Munoz C, et al. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism[J]. J Neurol Sci, 2008, 275(1-2): 121-127.
|
| 2 |
Abdelghani M, El-Shedoudy SAO, Nassif M, et al. Management of patients with patent foramen ovale and cryptogenic stroke: an update[J]. Cardiology, 2019, 143(1): 62-72.
|
| 3 |
Bayar N, Arslan Ş, Çağırcı G, et al. Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients[J]. J Stroke Cerebrovasc Dis, 2015, 24(6): 1282-1286.
|
| 4 |
Sauza-Sosa JC, Millan-Iturbe O. Patent foramen ovale "high-risk" anatomy: contemporary echocardiography evaluation[J]. Mayo Clin Proc, 2020, 95(2): 415-416.
|
| 5 |
Mojadidi MK, Zaman MO, Nietlispach F, et al. The dangerous patent foramen ovale: device closure for stroke patients with high-risk patent foramen ovale[J]. J Am Soc Echocardiogr, 2019, 32(10): 1366-1367.
|
| 6 |
Nakayama R, Takaya Y, Akagi T, et al. Identification of high-risk patent foramen ovale associated with cryptogenic stroke: development of a scoring system[J]. J Am Soc Echocardiogr, 2019, 32(7): 811-816.
|
| 7 |
Schuchklenz HW, Weihs W, Hoener S, et al. The association between the diameter of a patent foramen oval and the risk of cerebrovascular events[J]. Am J Med, 2000, 109(6): 456-462.
|
| 8 |
Collado FMS, Poulin MF, Murphy JJ, et al. Patent foramen ovale closure for stroke prevention and other disorders[J]. J Am Heart Assoc, 2018, 7(12): pii: e007146.
|
| 9 |
Kumar P, Rusheen J, Tobis JM. A comparison of methods to determine patent foramen ovale size[J]. Catheter Cardiovasc Interv, 2020, 96(6): E621-E629.
|
| 10 |
Mas JL, Arquizan C, Lamy C, et al. Patent foramen ovale and atrial septal aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both[J]. N Engl J Med, 2001, 345: 1740-1746.
|
| 11 |
De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications[J]. Stroke, 2000, 31(10): 2407-2413.
|
| 12 |
Jung JM, Lee JY, Kim HJ, et al. Patent foramen ovale and infarct volume in cryptogenic stroke[J]. J Stroke Cerebrovasc Dis, 2013, 22(8): 1399-1404.
|
| 13 |
Di Tullio MR, Jin Z, Russo C, et a1. Patent foramen ovale,subclinical cerebrovascular disease,and ischemic stroke in a population-based cohort[J]. J Am Coll Cardiol, 2013, 62(1): 35-41.
|
| 14 |
Mahfouz RA, Alawady WS, Salem A, et a1. Atrial dyssynchrony and left atrial stiffness are risk markers for cryptogenic strock in patients with patent foramen ovale[J]. Echocardiography, 2017, 34(12): 1888-1894.
|
| 15 |
Holda MK, Koziej M. Morphometric features of patent foramen ovale as a risk factor of cerebrovascular accidents: a systematic review and meta-analysis[J]. Cerebrovasc Dis, 2020, 49(1): 1-9.
|
| 16 |
Schuchlenz HW, Saurer G, Weihs W, et al. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events[J]. J Am Soc Echocardiogr, 2004, 17(3): 231-233.
|
| 17 |
Alegría-Barrero E, Alegría-Barrero A, Gavira Gómez JJ, et al. Chiari's network and paroxysmal atrial fibrillation[J]. Rev Esp Cardiol, 2011, 64(8): 727-728.
|
| 18 |
Monte I, Grasso S, Licciardi S, et al. Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale[J]. Eur J Echocardiogr, 2010, 11(3): 245-249.
|
| 19 |
Shub C, Tajik AJ, Seward JB, et a1. Detecting intrapulmonary right-to-left shunt with contrast echocardiography.Observations in a patient with diffuse pulmonary arteriovenous fistulas[J]. Mayo Clin Proc, 1976, 51(2): 81-84.
|
| 20 |
李越, 翟亚楠, 魏丽群, 等. 经食管与经胸超声心动图造影检出卵圆孔未闭右向左分流效果比较[J/CD] . 中华医学超声杂志(电子版), 2014, 10(11): 44-48.
|
| 21 |
Lam YY, Yu CM, Zhang Q, et al. Enhanced detection of patent foramen ovale by systematic transthoracic saline contrast echocardiography[J]. Int J Cardiol, 2011, 152(1): 24-27.
|
| 22 |
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med, 2017, 377(11): 1011-1021.
|
| 23 |
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med, 2017, 377(11): 1033-1042.
|
| 24 |
Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J]. N Engl J Med, 2017, 377(11): 1022-1032.
|
| 25 |
Kokkinidis DG, Palaiodimos L, Mastoris I, et al. The best DEFENSE for high-risk patent foramen ovale: an updated meta-analysis of six randomized trials[J]. Arch Cardiovasc Dis, 2019, 112(3): 150-152.
|
| 26 |
Lee PH, Song J-K, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial[J]. J Am Coll Cardiol, 2018, 71(20): 2335-2342.
|
| 27 |
Takafuji H, Hosokawa S, Ogura R, et al. Percutaneous transcatheter closure of highrisk patent foramen ovale in the elderly[J]. Heart Vessels, 2019, 34(10): 1657-1662.
|
| 28 |
Diener HC, Grau AJ, Baldus S, et al. Cryptogenic stroke and patent foramen ovale: S2e guidelines[J]. Nervenarzt, 2018, 89(10): 1143-1153.
|
| 29 |
Kuijpers T, Spencer FA, Siemieniuk R, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline[J]. BMJ, 2018, 362: k2515.
|
| 30 |
中华医学会心血管内科分会, 中国医师协会心血管内科分会. 卵圆孔未闭预防性封堵术中国专家共识[J]. 中国循环杂志, 2017, 32(3): 209-214.
|